Video Summary of Consensus Guidance: Monitoring Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes (T1D) in Children

A visual summary of the consensus-based monitoring framework for children and adolescents who have tested positive for islet autoantibodies (AAbs) in pre-Stage 3 type 1 diabetes (T1D). Drawing from the Breakthrough T1D Consensus Guidance (Phillip M et al., Diabetes Care, 2024), age-stratified monitoring protocols across Stage 1 and Stage 2 T1D are outlined, including HbA1c and random blood glucose assessment frequencies by age group (under 3 years, 3–9 years, over 9 years) and self-monitoring of blood glucose (SMBG) schedules for multiple AAb-positive children. Intended to support understanding of pediatric-specific monitoring considerations.

MAT-US-2605664 v1.0-P Exp Date: 06/01/2028